Table 1.
Increase in barrier function |
Maintenance of epithelial tight junctions integrity |
Increase mucin production (Globet cells) |
Increase in trefoil factors and defensins production (Paneth Cells) |
Modulation of immune response |
Increase secretory IgA |
Production of anti-inflammatory cytokines and inhibition of pro-inflammatory cytokines |
Promotion tolerogenic dendritic cells and regulatory T cells |
Enhance of natural killer activity |
Antagonism of pathogens |
Direct killing of bacteria |
Reduction of pathogen adherence |
Inhibition of pathogenic bacteria growth by antimicrobial and antitoxin compound production (i.e., SCFA, bacteriocins and microcins) |
Production of substances |
Production of enzymatic activities and/or beneficial metabolites to the host |
Promotion pain relief in visceral hyperalgesia |
SCFA: Short chain fatty acids.